Navigation Links
Grupo Aeroportuario del Pacifico, S.A.B. de C.V. Announcement Regarding Swine Flu Virus
Date:4/27/2009

GUADALAJARA, JALISCO, Mexico, April 27 /PRNewswire-FirstCall/ -- Grupo Aeroportuario del Pacifico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) ("the Company" or "GAP" today announced the following:

On Sunday, April 26, 2009, the Mexican National Health Department confirmed the existence of Type A and B viruses in humans as well as the circulation of another strain of the virus, called Swine Influenza (Swine Flu Virus).

As a result of the alerts, the Health Departments located in most of the Mexican states where GAP's airports operate initiated epidemiology surveillance posts to be on the lookout for any persons affected by the symptoms, in order to maintain control over this outbreak and grant timely attention and follow up to those persons showing any signs of the virus. These symptoms are:

  • Fever higher than 102.2 degrees F (39 degrees C),
  • Frequent and intense cough,
  • Headache,
  • Loss of appetite,
  • Nasal congestion, and
  • Muscle and joint pain.

We are offering the health authorities all of the support required for any activity they consider necessary at each of our airports.

With the support of the airlines and the authorities that interact at each of the terminal areas, we will be able to detect any passenger showing any of these signs. These passengers must be channeled via the control posts so that the Health Department can review the situation and, if necessary, take samples to rule out if the passenger is a carrier of the swine influenza virus.

Today, operations at the airports that GAP operates remained normal, that is, there were no cancellations of national or international flights.

The Company, together with the airport authorities and the airlines will be in constant communications in order to update the market on instructions from the Health Department.

It is important to mention that at this moment we do not know the full impact that this situation will have of passenger traffic; this will depend on the amount of time that the risk is prolonged.

If necessary, the Company will issue another press release to inform regarding the measures established at the Company's airports.

Company Description:

Grupo Aeroportuario del Pacifico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico's Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Bajio, Morelia, Aguascalientes, Mexicali and Los Mochis. In February 2006, GAP's shares were listed on the New York Stock Exchange under the ticker symbol "PAC" and on the Mexican Stock Exchange under the ticker symbol "GAP".

This press release may contain forward-looking statements. These statements are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial conditions, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and article 42 of the "Ley del Mercado de Valores," GAP has implemented a "whistleblower" program, which allows complainants to anonymously and confidentially report suspected activities that may involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party that is in charge of collecting these complaints, is 800-759-0045. GAP's Audit Committee will be notified of all complaints for immediate investigation.

    In the U.S.
    Maria Barona / Kenia Vargas
    +1-212 406 3691
    gap@i-advize.com

    In Mexico
    Miguel Aliaga, Investor Relations Officer
    i-advize Corporate Communications
    Grupo Aeroportuario del Pacifico, S.A.B. de C.V.
    01 (333) 8801100 ext 216
    maliaga@aeropuertosgap.com.mx


'/>"/>
SOURCE Grupo Aeroportuario del Pacifico, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Grupo Casa Saba Announces Third Quarter 2007 Results
2. Grupo Casa Saba Announces Fourth Quarter 2007 Results
3. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
4. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
5. Grupo Casa Saba Quarterly Earnings Report 3Q08
6. Grupo Casa Saba Announces 4Q08 Earnings Results
7. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
8. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
9. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
10. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
11. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical ... York, NY, on December 3rd, to benefit Holy Name Medical Center's programs and ... which raised over $1 million - the largest event in the Center's history, ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching ... innovative Unified Instance Manager architecture, meeting the needs of multichannel growth and ... the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... 2016 Research and Markets has announced the ... to their offering. ... The global travel vaccines market to grow at a CAGR ... the present scenario and the growth prospects of the global travel ... considers the revenue generated from the sales of various vaccines administered ...
Breaking Medicine Technology: